(redirected from Broad-spectrum antibiotic)
Also found in: Dictionary, Thesaurus, Medical, Encyclopedia, Wikipedia.
See: drug
References in periodicals archive ?
8 percent using a broad-spectrum antibiotic and 18.
However, the effect of these messages may be limited because of lack of clarity regarding what constitutes a narrow- versus broad-spectrum antibiotic.
On multivariate analysis, the strongest independent predictors for prescribing broad-spectrum antibiotics for acute upper respiratory tract infections were physician specialty and geographic region.
Afterward, patients were continued on oral broad-spectrum antibiotic coverage for a minimum of 1 week.
AzaSite contains the drug azithromycin, a broad-spectrum antibiotic formulated with DuraSite[R], InSite's patented drug-delivery vehicle.
We intend to rapidly move forward with the development of our IV dosage form to meet the need for a broad-spectrum antibiotic in the hospital setting, particularly one that is active against quinolone-resistant MRSA.
AzaSite contains the drug azithromycin, a broad-spectrum antibiotic, formulated with DuraSite([R]), InSite Vision's patented drug-delivery vehicle.
Funding from the financing will allow for the initiation of Phase 3 studies of Paratek's most advanced broad-spectrum antibiotic, PTK 0796, which is being developed to treat serious, often life-threatening infections that require a hospital visit such as complicated skin and skin structure infections (cSSSI) and moderate to severe community-acquired pneumonias (CAP), including those caused by multi-drug resistant bacteria.
The financing will also help Paratek continue development of a novel community-based broad-spectrum antibiotic that has been designed specifically to treat MRSA and other important bacterial infections in the physician's office setting.
PPI-0903 has also demonstrated in vitro activity against many common Gram-negative bacteria, exemplifying its potential as a broad-spectrum antibiotic.
Unlike many antibiotic drugs which act on biochemical targets and to which bacterial resistance readily develops, PolyMedix's antimicrobial compounds have the potential to be rapid acting broad-spectrum antibiotic because they appear to work biophysically by a novel mechanism that targets and disrupts bacterial cell membranes.
Doripenem, a broad-spectrum antibiotic, is a new member of the carbapenem class of beta-lactam antibiotics.